Some items on our site have recently moved. Visit our News Hub for selected articles, special reports, podcasts and other resources.
Read our recent coverage
-
Japanese stakeholders have mostly welcomed the industry ministry’s recent guidelines on licensing negotiations for essential technologies
-
Chinese courts using anti-suit injunctions against lawsuits in disputes over standard essential patents, or SEPs
-
Big Tech faces the prospect of enforcers coordinating antitrust and regulatory probes at both the national and the European level
Learn More About MLex
Reporting on regulatory risk for all.
Our coverage & expertise
Request a Free Trial of MLex
Other ways to get in touch
You can also call us on:
- UK (Toll Free) +44 800 999 3237
- US (Toll Free) +1 800 356 6547
- Hong Kong +852 2965 1424